Topic: mergers and acquisitions
The deal will further Roche’s precision medicine plans while allowing Foundation to retain autonomy and continue to work with other biopharmas.
European CRO Optimapharm has expanded operations to the U.S., opening a new office in New York and appointing a VP for development in the Americas.
Sirtex Medical accepted a $1.4 billion buyout offer from China’s CDH Investments and China Grand Pharmaceutical and Healthcare.
Admescope has acquired Swedish CRO MetaSafe, which focuses on metabolic research and drug biotransformation. Financial terms were not disclosed.
Nadim Ahmed said Celgene’s arm’s-length relationship with the biotech it bought for $7.2 billion three years ago led to a substandard filing.
Stryker has offered to acquire its rival, Boston Scientific, in what would be one of the largest medical device deals on record, according to reports.
LabCorp acquired postmarket services provider Sciformix and plans to integrate it with Covance. The terms of the deal were not disclosed.
The takeover will give Philips a 3D cardiac imaging system to slot into its portfolio of interventional imaging technologies.
Aravive will merge with the struggling Versartis and gain access to the Nasdaq
Allergan acquired an NMDA receptor modulator discovered by Aptinyx, planning to pair it with its rapastinel depression therapy currently in phase 3.